L
Leslie Z. Sokolow
Researcher at Battelle Memorial Institute
Publications - 15
Citations - 2807
Leslie Z. Sokolow is an academic researcher from Battelle Memorial Institute. The author has contributed to research in topics: Live attenuated influenza vaccine & Vaccination. The author has an hindex of 12, co-authored 15 publications receiving 2504 citations. Previous affiliations of Leslie Z. Sokolow include Centers for Disease Control and Prevention & National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
Lisa A. Grohskopf,Leslie Z. Sokolow,Leslie Z. Sokolow,Sonja J. Olsen,Joseph S. Bresee,Karen R. Broder,Ruth A. Karron +6 more
TL;DR: This report updates the 2017–18 recommendations of the Advisory Committee on Immunization Practices regarding the use of seasonal influenza vaccines in the United States and focuses on the recommendations for use of vaccines for the prevention and control of influenza during the 2018–19 season.
Journal ArticleDOI
Prevention and Control of Seasonal Influenza with Vaccines.
Lisa A. Grohskopf,Leslie Z. Sokolow,Karen R. Broder,Sonja J Olsen,Ruth A. Karron,Daniel B. Jernigan,Joseph S. Bresee +6 more
TL;DR: In light of concerns regarding low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013-14 and 2015-16 seasons, ACIP makes the interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used.
Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014
Lisa A. Grohskopf,David K. Shay,Tom T. Shimabukuro,Leslie Z. Sokolow,Wendy A. Keitel,Joseph S. Bresee,Nancy J. Cox +6 more
TL;DR: This report updates the 2012 recommendations by CDC's Advisory Committee on Immunization Practices regarding the use of influenza vaccines for the prevention and control of seasonal influenza and describes recently approved vaccines, including LAIV4, IIV4, trivalent cell culture-based inactivated influenza vaccine (ccIIV3), andTrivalent recombinant influenza vaccine(RIV3).
Journal ArticleDOI
Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 Influenza Season
Lisa A. Grohskopf,Leslie Z. Sokolow,Leslie Z. Sokolow,Karen R. Broder,Emmanuel B. Walter,Joseph S. Bresee,Alicia M. Fry,Daniel B. Jernigan +7 more
TL;DR: The CDC/ACIP recommendations for use of influenza vaccines in various populations for the 2017-18 season, discussion of vaccines expected to be available, contraindications and precautions to vaccination, and relevant figures and tables may be found in the above-referenced MMWR document.
Journal ArticleDOI
Effectiveness of Seasonal Trivalent Influenza Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based Case-Control Study During the 2010–2011 and 2011–2012 Influenza Seasons
Mark G. Thompson,De-Kun Li,Pat Shifflett,Leslie Z. Sokolow,Leslie Z. Sokolow,Jeannette Ferber,Samantha Kurosky,Sam Bozeman,Sue Reynolds,Roxana Odouli,Michelle L. Henninger,Tia L. Kauffman,Lyndsay A. Avalos,Sarah Ball,Jennifer Williams,Stephanie A. Irving,David K. Shay,Allison L. Naleway +17 more
TL;DR: Influenza vaccination reduced the risk of ARI associated with laboratory-confirmed influenza among pregnant women by about one-half, similar to VE observed among all adults during these seasons.